0001209191-19-041791.txt : 20190711
0001209191-19-041791.hdr.sgml : 20190711
20190711131547
ACCESSION NUMBER: 0001209191-19-041791
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190709
FILED AS OF DATE: 20190711
DATE AS OF CHANGE: 20190711
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: POTTER MYRTLE S
CENTRAL INDEX KEY: 0001214130
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38667
FILM NUMBER: 19950808
MAIL ADDRESS:
STREET 1: 10 FINDERNE AVE
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Urovant Sciences Ltd.
CENTRAL INDEX KEY: 0001740547
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D0
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 5281 CALIFORNIA AVENUE
STREET 2: SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92617
BUSINESS PHONE: 949-226-6029
MAIL ADDRESS:
STREET 1: 5281 CALIFORNIA AVENUE
STREET 2: SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-07-09
0
0001740547
Urovant Sciences Ltd.
UROV
0001214130
POTTER MYRTLE S
C/O UROVANT SCIENCES, INC.
5281 CALIFORNIA AVENUE, SUITE 100
IRVINE
CA
92617
1
0
0
0
Stock Option (Right to Buy)
8.78
2019-07-09
4
A
0
25000
0.00
A
2029-07-09
Common Shares
25000
25000
D
The shares underlying the option shall vest and become exercisable on July 9, 2020, subject to the Reporting Person providing continuous service to the Issuer through such vesting date.
/s/ Bryan Smith, Attorney-in-Fact
2019-07-11